Personalized Feedback for Smokers With Elevated Anxiety Sensitivity
| Status: | Recruiting |
|---|---|
| Conditions: | Anxiety, Smoking Cessation, Neurology, Tobacco Consumers |
| Therapuetic Areas: | Neurology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 8/23/2018 |
| Start Date: | August 23, 2017 |
| End Date: | December 2018 |
| Contact: | Angelina Mayorga, BS |
| Email: | namayorga@uh.edu |
| Phone: | 713-743-8056 |
This project will develop and refine a computer-delivered integrated Personalized Feedback
Intervention (PFI) that directly addresses smoking and anxiety sensitivity (AS). The PFI will
focus on feedback about smoking behavior, AS, and adaptive coping strategies.
Intervention (PFI) that directly addresses smoking and anxiety sensitivity (AS). The PFI will
focus on feedback about smoking behavior, AS, and adaptive coping strategies.
The primary goal of the research study is to investigate the efficacy of a brief,
personalized computer-delivered transdiagnostic intervention (PFI) that addresses smoking and
anxiety sensitivity (AS) to reduce smoking, increase quit attempts, reduce perceived barriers
to cessation, reduce AS and negative affective symptoms, and increase adaptive coping skills
compared to a smoking information only control. To address this aim, we will implement a
randomized controlled trial that will employ a longitudinal experimental design and involve
three stages: (a) phone-screener (pre-screener); (b) baseline appointment consisting of a
pre-intervention assessment (eligibility), random assignment to a one-session
computer-delivered intervention (PFI versus smoking information control with no personalized
feedback), and a post-intervention assessment; (c) 1-month follow-up. Assessments will
include a multi-method approach, including biological, behavioral, and self-report methods.
personalized computer-delivered transdiagnostic intervention (PFI) that addresses smoking and
anxiety sensitivity (AS) to reduce smoking, increase quit attempts, reduce perceived barriers
to cessation, reduce AS and negative affective symptoms, and increase adaptive coping skills
compared to a smoking information only control. To address this aim, we will implement a
randomized controlled trial that will employ a longitudinal experimental design and involve
three stages: (a) phone-screener (pre-screener); (b) baseline appointment consisting of a
pre-intervention assessment (eligibility), random assignment to a one-session
computer-delivered intervention (PFI versus smoking information control with no personalized
feedback), and a post-intervention assessment; (c) 1-month follow-up. Assessments will
include a multi-method approach, including biological, behavioral, and self-report methods.
Inclusion Criteria:
- Elevated anxiety sensitivity defined as an ASI-III score of at least 17
- Daily smoking for at least one year (minimum of 5 cigarettes per day and biochemically
confirmed via Carbon Monoxide [CO] analysis at least 4 ppm)
- Not presently engaged in a quit attempt
- Not currently engaged in mental health treatment
- Capable of providing informed consent
- Willing to attend all study visits and comply with the protocol
Exclusion Criteria:
- Adults unable to consent
- Individuals who are not yet adults (infants, children, teenagers)
- Pregnant women
- Prisoners
- Students for whom you have direct access to/influence on grades
- Use of other tobacco products
- Currently suicidal or high suicide risk
- Currently psychotic or high psychotic risk
- Insufficient command of English to participate in assessment or treatment
We found this trial at
1
site
Houston, Texas 77204
Principal Investigator: Lorra L. Garey, MA
Phone: 713-743-8056
Click here to add this to my saved trials
